Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01732848 · ClinicalTrials.gov registry record
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 113
- Enrollment target
NCT01732848 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 113 participants.
The verdict
NCT01732848 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the rate of kidney or heart impairment, if any, in subjects who received BMS-986094 (INX-08189) in Phase 1 clinical trials
Interventions
- DRUG BMS-986094/INX-08189
- DRUG Placebo matching BMS-986094/INX-08189
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01732848
The ClinicalTrials.gov registry entry for NCT01732848 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BMS-986094/INX-08189 is the first listed.
NCT01732848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01732848 about?
NCT01732848 is a clinical study titled "A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)". The purpose of this study is to determine the rate of kidney or heart impairment, if any, in subjects who received BMS-986094 (INX-08189) in Phase 1 clinical trials
What is the current status of trial NCT01732848?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2012-11. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01732848?
The interventions under investigation include: BMS-986094/INX-08189 (DRUG), Placebo matching BMS-986094/INX-08189 (DRUG).
Who is sponsoring clinical trial NCT01732848?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.